Lataa...

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Clin Transl Neurol
Päätekijät: Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://ncbi.nlm.nih.gov/pubmed/26783546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!